Long-term U.S. Treasury bonds have seen a sharp price drop but are now considered deeply oversold, with yields on 30-year bonds approaching a significant resistance level near 6%. The U.S. Treasury is expected to reduce auction sizes for long-dated bonds to manage funding costs, favoring shorter-term bills instead. This shift could stabilize or improve long bond prices, signaling a potential opportunity for investors as the worst of the decline may be behind us.
The story on long U.S. Treasury bonds is provided here with Pluang platform market data for context. For readers following U.S. stocks, here is Pluang's market snapshot as of Oct 13, 2026 21:21 WIB: out of 150 priced US stocks tradable on Pluang, 61 rose and 88 fell today. Notable movers include META at USD 766.97 with a 1-day change of +3.23%, CRM at USD 240.99 with +3.02%, and CAT at USD 776.73 with -2.83%.
Domino's Pizza reported Q3 2026 earnings per share of $4.60, beating analyst expectations of $4.37, while revenue grew modestly by 3.4% to $1.19 billion. Same-store sales growth was minimal at 0.3% in the U.S. and 0.2% internationally, reflecting com...
Citigroup reported Q3 2026 earnings that exceeded analyst expectations, with EPS of $2.85 beating the $2.65 estimate and revenue of $23.8 billion slightly above forecasts. The bank's profit rose 40%, driven by exceptional fixed-income trading, invest...
State Street is set to report its Q3 2026 earnings with forecasts showing a 31.3% increase in earnings and 14% revenue growth, driven by strong net interest income and service fees. Despite record assets under management, higher operating and technol...
Restaurant Technologies, Inc. (RTI) released its 2026 Impact Report highlighting significant progress in sustainability and operational efficiency. In 2025, RTI recycled 393 million pounds of used cooking oil and delivered 719.4 million pounds of fre...
Over 60 companies are actively developing more than 65 medical marijuana therapies targeting conditions like chronic pain, neurological disorders, and cancer symptoms. Key drugs such as ZYN-002 and CardiolRx are in late-stage trials, with others in e...
